These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25013416)
41. Massive low-attenuation mediastinal, retroperitoneal, and pelvic lymphadenopathy on CT from lymphangioleiomyomatosis. Case report. Woodring JH; Howard RS; Johnson MV Clin Imaging; 1994; 18(1):7-11. PubMed ID: 8180866 [TBL] [Abstract][Full Text] [Related]
42. Prevalence and clinical features of lymphedema in patients with lymphangioleiomyomatosis. Hoshika Y; Hamamoto T; Sato K; Eto H; Kuriyama S; Yoshimi K; Iwakami S; Takahashi K; Seyama K Respir Med; 2013 Aug; 107(8):1253-9. PubMed ID: 23688816 [TBL] [Abstract][Full Text] [Related]
43. Lymphangioleiomyomatosis initially presenting with abdominal pain: a case report. Lu HC; Wang J; Tsang YM; Lin MC; Li YW Clin Imaging; 2003; 27(3):166-70. PubMed ID: 12727053 [TBL] [Abstract][Full Text] [Related]
44. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report. De Rosa N Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060 [TBL] [Abstract][Full Text] [Related]
45. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Kumasaka T; Seyama K; Mitani K; Souma S; Kashiwagi S; Hebisawa A; Sato T; Kubo H; Gomi K; Shibuya K; Fukuchi Y; Suda K Am J Surg Pathol; 2005 Oct; 29(10):1356-66. PubMed ID: 16160479 [TBL] [Abstract][Full Text] [Related]
46. Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size. Avila NA; Dwyer AJ; Murphy-Johnson DV; Brooks P; Moss J AJR Am J Roentgenol; 2005 Feb; 184(2):459-64. PubMed ID: 15671364 [TBL] [Abstract][Full Text] [Related]
47. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex. Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139 [TBL] [Abstract][Full Text] [Related]
48. Involvement of lymphatics in lymphangioleiomyomatosis. Glasgow CG; Taveira-DaSilva A; Pacheco-Rodriguez G; Steagall WK; Tsukada K; Cai X; El-Chemaly S; Moss J Lymphat Res Biol; 2009 Dec; 7(4):221-8. PubMed ID: 20143921 [TBL] [Abstract][Full Text] [Related]
49. Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis. Di Marco F; Terraneo S; Imeri G; Palumbo G; La Briola F; Tresoldi S; Volpi A; Gualandri L; Ghelma F; Alfano RM; Montanari E; Gorio A; Lesma E; Peron A; Canevini MP; Centanni S PLoS One; 2016; 11(5):e0155331. PubMed ID: 27171001 [TBL] [Abstract][Full Text] [Related]
51. A case report of lymphangioleiomyomatosis with retroperitoneal masses in pregnancy. Zhu Y; Wang C; Ding J; Yang M; Bo Y; Ma M; Hu H; Cheng J; Han L; Wang Y Front Med (Lausanne); 2023; 10():1313503. PubMed ID: 38188337 [TBL] [Abstract][Full Text] [Related]
53. Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment. Meraj R; Wikenheiser-Brokamp KA; Young LR; McCormack FX Semin Respir Crit Care Med; 2012 Oct; 33(5):486-97. PubMed ID: 23001803 [TBL] [Abstract][Full Text] [Related]
54. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis. De Pauw RA; Boelaert JR; Haenebalcke CW; Matthys EG; Schurgers MS; De Vriese AS Am J Kidney Dis; 2003 Apr; 41(4):877-83. PubMed ID: 12666075 [TBL] [Abstract][Full Text] [Related]
55. Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment. Liu Y; Guo Z; Zhao C; Li X; Liu H; Chen J Onco Targets Ther; 2018; 11():5339-5347. PubMed ID: 30214240 [TBL] [Abstract][Full Text] [Related]
56. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM). Goncharova EA; Goncharov DA; Fehrenbach M; Khavin I; Ducka B; Hino O; Colby TV; Merrilees MJ; Haczku A; Albelda SM; Krymskaya VP Sci Transl Med; 2012 Oct; 4(154):154ra134. PubMed ID: 23035046 [TBL] [Abstract][Full Text] [Related]
58. Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Young LR; Franz DN; Nagarkatte P; Fletcher CDM; Wikenheiser-Brokamp KA; Galsky MD; Corbridge TC; Lam AP; Gelfand MJ; McCormack FX Chest; 2009 Sep; 136(3):926-933. PubMed ID: 19349386 [TBL] [Abstract][Full Text] [Related]
59. Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases. Gyure KA; Hart WR; Kennedy AW Int J Gynecol Pathol; 1995 Oct; 14(4):344-51. PubMed ID: 8598338 [TBL] [Abstract][Full Text] [Related]
60. A case of lymphangioleiomyomatosis associated with endometrial cancer and severe systemic lupus erythematosus. Suzuki K; Nagasaka K; Oda K; Abe H; Maeda D; Matsumoto Y; Arimoto T; Kawana K; Fukayama M; Osuga Y; Fujii T BMC Cancer; 2016 Jul; 16():390. PubMed ID: 27377753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]